DVT is a Mesa, Arizona based biomaterial storage and transport start-up initially focusing on the defense medical market to increase levels of care for pre-hospital trauma injuries, but have many applications in disaster relief, refugee care, and aero medical transportation. Our device, the HemaPorter, is a patent pending storage and transportation device designed to deliver whole blood and/or biomaterials to the very point of injury, drastically increasing the survivability rate of critical casualties. Our device is rechargeable, designed to maintain sub 40℉ payload temperatures for over 4+ days in extreme (100+℉) temperatures, and to provide real time data confirming cold chain quality of payload. Data tracking will allow viable blood products to extend from less than 24 hours to over 30 days (or as long as preserving agent allows) in the field if docked, decreasing wastage and unnecessary transportation. Remote data access gives hospital inventory managers quality data to send o...
DVT is a Mesa, Arizona based biomaterial storage and transport start-up initially focusing on the defense medical market to increase levels of care for pre-hospital trauma injuries, but have many applications in disaster relief, refugee care, and aero medical transportation. Our device, the HemaPorter, is a patent pending storage and transportation device designed to deliver whole blood and/or biomaterials to the very point of injury, drastically increasing the survivability rate of critical casualties. Our device is rechargeable, designed to maintain sub 40℉ payload temperatures for over 4+ days in extreme (100+℉) temperatures, and to provide real time data confirming cold chain quality of payload. Data tracking will allow viable blood products to extend from less than 24 hours to over 30 days (or as long as preserving agent allows) in the field if docked, decreasing wastage and unnecessary transportation. Remote data access gives hospital inventory managers quality data to send out supplies further than currently done while being able to restock unused inventory. Current designs require blood to be thrown away if sent out of a hospital setting due to a lack of transparency in the cold chain. Mobile cooling will allow for onsite blood collection which can allow for mobile and pop up blood banking in an area of high need where not currently possible. The HemaPorter will be capable of being charged via hardwired dock unit, in a vehicle or any setting with a power supply, and can be transported via vest mounted pouch, backpack, truck, fixed/rotary wing aircraft, or UAV. The current design weighs 8.5lbs but we are targeting a 6lb design that can charge under 2 hours without a freezer unit or hospital setting. Larger models for fixed wing long haul transport are planned. All features and uses will drastically decrease mortality rates for critical care casualties requiring fluid augmentation as well as vaccination and pharmaceutical delivery. Future state to include global inventory management software allowing rapid shifting of inventory where it's needed most. This software will allow health systems to track and move perishable biomedical inventory, decreasing wastage and increasing use of critical supplies. There are many non military applications for this technology as patients are transported from facility to facility via rotor or fixed wing aircraft as well as uses for lab/tissue samples, vaccines, pharmaceuticals and even human organs.
More information

Employees

Travis Witzke
Admin
Travis Witzke CEO I am an ASU BS & MBA with a background in entrepreneurship, medical transportation and military operations.